Boiron SA

€19.90As of Sun 8 Nov 2026, 12:00 UTC
EPA:BOIHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (7.78%)
Div yield 6.78%
ROE 7.04%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM 13.19
TSR TTM (25.69%)
Mkt cap €345.5M
ROIC 8.24%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€23
14.66%
11.68%
Hold 6|1|11|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.33
0.33
0.35
0.40
20.23%
20.03%
17.47%
29.87%
Revenue€M
20.98
21.53
21.05
20.48
10.38%
11.62%
10.03%
1.72%
Peers (US$388.0M)
Cap (US$)
PE
1.154B
16.23x
85.49M
—
45.46M
—
386.0M
22.71x
Capital
TTM
5Y
10Y
Leveragex
3.522
0.214
0.168
EBIT/Intx
0.222
0.114
0.094
Own earn%
39.25
(1.06)
(5.34)
Sh yield%
22.16
31.40
32.83
Owners
Insiders/Inst%
5.22
87.22
Short interest%
2.80
SBC / revenue%
2.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
29–37
$1 testx
0.0
Incr. ROIC%
11